Live Breaking News & Updates on European Pharmaceutical

Stay updated with breaking news from European pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NICE recommends first licenced treatment for AL amyloidosis

Eligible individuals in England and Wales can access the first licensed treatment for amyloid light-chain amyloidosis on the NHS. The . ....

United Kingdom , Northern Ireland , Amanda Cunnington , Sophie Castell , National Institute For Health , Janssen Biotech Inc , Russell Publishing , Janssen Pharmaceutical Companies , Care Excellence , Chief Executive , Front Immunology , Senior Director , Patient Access , Cilag Limited , European Pharmaceutical , Russell Publishing Limited ,

Novel immunotherapy approved for melanoma

Amtagvi is the first tumour-derived autologous T cell immunotherapy therapy to be approved by the US Food and Drug Administration for certain adults with unresectable or metastatic. ....

United States , Jason Bock , Alexander Shoushtari , Frederick Vogt , Peter Marks , Steven Rosenberg , Iovance Biotherapeutics , Surgery Branch , Cell Therapy Manufacturing Center , National Cancer Institute , Russell Publishing , Cellular Therapy Service , Memorial Sloan Kettering Cancer Center , Drug Administration , Biologics Evaluation , Cancer Institute , Interim Chief Executive Officer , Jae Park , Melanoma Oncologist , Cellular Therapist , Sloan Kettering Cancer Center , European Pharmaceutical , Russell Publishing Limited ,

BioNTech agrees collaboration to accelerate autologous CAR-T therapies

BioNTech SE and Autolus Therapeutics have agreed to collaborate to advance autologous CAR-T cell therapies.
Under the terms of the agreement, BioNTech will pay $50 million. ....

United States , United Kingdom , Ugur Sahin , Russell Publishing , Chief Executive Officer , European Pharmaceutical , Russell Publishing Limited ,

First-of-a-kind psoriasis study outcomes revealed

Topline data from a novel Phase III study show that the biologic TREMFYA ® facilitated rapid and significant clearance in moderate to severe scalp psoriasis and significant improvement in scalp. ....

United States , New York , Jennifer Davidson , Andrew Alexis , Russell Publishing , Maui Derm Hawaii , Psoriasis Scalp Severity Index , Scalp Surface Area , Clinical Dermatology , Vice Chair , Weill Cornell Medicine , Lead Study , Vice President , Medical Affairs , Johnson Innovative , European Pharmaceutical , Russell Publishing Limited ,

GenAI in pharma: where are we today? -January 12, 2024 at 05:31 am EST

A recent survey from the Pistoia Alliance revealed that AI and machine learning will be the top technology investment for 60 percent of life sciences companies over the next two years.1

AI and. ....

Caroline Peachey , Pistoia Alliance , Life Sciences At Clarivate , Product Development , Russell Publishing , Life Sciences , Pharmaceutical Product Development , Chief Strategy Officer , General Manager , Clinical Data Management , Chief Commercial Officer , European Pharmaceutical , Russell Publishing Limited ,